Guselkumab treatment normalizes the stratum corneum ceramide profile and alleviates barrier dysfunction in psoriasis: results of a randomized controlled trial-Reference-Cited by-同舟云学术

Guselkumab treatment normalizes the stratum corneum ceramide profile and alleviates barrier dysfunction in psoriasis: results of a randomized controlled trial

Published:2024-08 Issue:8 Volume:65 Page:100591
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Rousel Jannik^ORCID,Mergen Catherine^ORCID,Bergmans Menthe E.,Bruijnincx Lisa J.^ORCID,de Kam Marieke L.,Klarenbeek Naomi B.,Niemeyer-van der Kolk Tessa,van Doorn Martijn B.A.^ORCID,Bouwstra Joke A.,Rissmann Robert^ORCID

Publisher

Elsevier BV

Reference95 articles.

1. Satisfaction of treatment with biologics is high in psoriasis: results from the Bio-CAPTURE network;van den Reek;Br. J. Dermatol.,2014

2. Epidermal Vascular Endothelial Growth factor production is Required for permeability barrier homeostasis, dermal Angiogenesis, and the development of epidermal hyperplasia: Implications for the pathogenesis of psoriasis;Elias;Am. J. Pathol.,2008

3. Psoriasis is a disease of the entire skin: non-lesional skin displays a prepsoriasis phenotype;Nosbaum;Eur. J. Dermatol.,2021

4. Genetics of psoriasis: evidence for Epistatic Interaction between skin barrier abnormalities and immune Deviation;Bergboer;J. Invest. Dermatol.,2012

5. Differentiation of involved and uninvolved psoriatic skin from healthy skin using noninvasive visual, colorimeter and evaporimeter methods;Pershing;Skin Res. Technol.,1995

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of ceramides in the disruption of the cutaneous permeability barrier, a common manifestation of skin disorders;Journal of Lipid Research;2024-08